Special Commentary: Supporting Innovation for Safe and Effective Minimally Invasive Glaucoma Surgery: Summary of a Joint Meeting of the American Glaucoma Society and the Food and Drug Administration, Washington, DC, February 26, 2014

Ophthalmology

Volumn 122, Issue 9, 2015, Pages 1795-1801

  Caprioli, Joseph ^a   Kim, Julie H ^b   Friedman, David S ^c   Kiang, Tina ^b   Moster, Marlene R ^d   Parrish, Richard K ^e   Rorer, Eva M ^b   Samuelson, Thomas ^f   Tarver, Michelle E ^b   Singh, Kuldev ^g   Eydelman, Malvina B ^b  

^a JULES STEIN EYE INSTITUTE   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f MINNESOTA EYE CONSULTANTS   (United States)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; ANATOMICAL VARIATION; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL TRIAL (TOPIC); DISEASE SEVERITY; FOOD AND DRUG ADMINISTRATION; GLAUCOMA; GLAUCOMA SURGERY; GLAUCOMA SURGICAL DEVICE; HUMAN; HYPOTONY MACULOPATHY; INTRAOCULAR PRESSURE; MEDICAL SOCIETY; MINIMALLY INVASIVE SURGERY; NOTE; OPHTHALMOLOGICAL SURGICAL EQUIPMENT; PATIENT SAFETY; PATIENT SELECTION; PHYSIOLOGICAL PROCESS; POPULATION; PRIORITY JOURNAL; UNITED STATES; VISUAL FIELD; VISUAL IMPAIRMENT; BIOASSAY; DEVICE SAFETY; DEVICES; EXPERIMENTAL THERAPY; FILTERING OPERATION; OPHTHALMOLOGY; ORGANIZATION; ORGANIZATION AND MANAGEMENT;

CONGRESSES AS TOPIC; ENDPOINT DETERMINATION; EQUIPMENT SAFETY; FILTERING SURGERY; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MINIMALLY INVASIVE SURGICAL PROCEDURES; OPHTHALMOLOGY; SOCIETIES, MEDICAL; THERAPIES, INVESTIGATIONAL; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VISUAL FIELDS;

EID: 84939771283     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2015.02.029     Document Type: Article

References (28)

1. United States Food and Drug Administration. Supporting Innovation for Safe and Effective Minimally Invasive Glaucoma Surgery. Available at: http://www.fda.gov/downloads/MedicalDevices/NewsEvents/WorkshopsConferences/UCM390323.pdf. Accessed October 9, 2014.
2. American Glaucoma Society. FDA-AGS Workshop Program. Available at: http://www.americanglaucomasociety.net/client-data/files/2014/375-fdaagsmigsworkshopprogram-4publish-01.24.14-final.pdf. Accessed October 9, 2014.
3. United States Food and Drug Administration. Device Advice: Comprehensive Regulatory Assistance. Available at: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/Overview/ClassifyYourDevice/default.htm. Accessed October 9, 2014.
4. American National Standards Institute for Ophthalmics Z80.27-2014: Implantable Glaucoma Devices 2014 Alexandria: The Vision Council
5. H. Saheb, and I. Ahmed Micro-invasive glaucoma surgery: current perspectives and future directions Curr Opin Ophthalmol 232 2012 96 104
6. C.L. Hays, V. Gulati, S. Fan, and et al. Improvement in outflow facility by two novel microinvasive glaucoma surgery implants Invest Ophthalmol Vis Sci 55 2014 1893 1900
7. E. Hodapp, R.K. Parrish II, and D.R. Anderson Clinical decisions in glaucoma 1993 The CV Mosby Co St Louis 52 61
8. R.P. Mills, D.L. Budenz, P.P. Lee, and et al. Categorizing the stage of glaucoma from prediagnosis to end-stage disease Am J Ophthalmol 141 2006 24 30
9. H.D. Jampel, D. Friedman, H. Quigley, and et al. Agreement among glaucoma specialists in assessing progressive disc changes from photographs in open-angle glaucoma patients Am J Ophthalmol 147 2009 39 44
10. R.A. Lewis Complications: hypotony J.A. Giaconi, S.K. Law, A.L. Coleman, J. Caprioli, Pearls of Glaucoma Management 2010 Springer-Verlag Berlin 445 448
11. S.J. Gedde, J.C. Schiffman, W.J. Feuer, and et al. Tube Versus Trabeculectomy Study Group. The Tube Versus Trabeculectomy Study: design and baseline characteristics of study patients Am J Ophthalmol 140 2005 275.e1 275.e14
12. L.A. Fannin, J.C. Schiffman, and D.L. Budenz Risk factors for hypotony maculopathy Ophthalmology 110 2003 1185 1191
13. S.S. Hayreh Anterior ischemic optic neuropathy. IV. Occurrence after cataract extraction Arch Ophthalmol 98 1980 1410 1416
14. R.F. Steinert, J.G. Oster, and J.M. Francis Postoperative retinal ischemia with self-sealing cataract surgery incisions Am J Ophthalmol 123 1997 124 125
15. D.J. Rhee, R.E. Peck, J. Belmont, and et al. Intraocular pressure alterations following intravitreal triamcinolone acetonide Br J Ophthalmol 90 2006 999 1003
16. M.C. Leske, A. Heijl, L. Hyman, and et al. Early Manifest Glaucoma Trial Group. Early Manifest Glaucoma Trial: design and baseline data Ophthalmology 106 1999 2144 2153
17. J. Katz, N. Congdon, and D.S. Friedman Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment Arch Ophthalmol 117 1999 1137 1142
18. D.C. Musch, B.W. Gillespie, P.R. Lichter, and et al. Visual field progression in the Collaborative Initial Glaucoma Treatment Study: the impact of treatment and other baseline factors Ophthalmology 116 2009 200 207
19. AGIS Investigators The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma Am J Ophthalmol 134 2002 499 512
20. R. McKean-Cowdin, Y. Wang, J. Wu, et al. Los Angeles Latino Eye Study Group Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study Ophthalmology 115 2008 941 948
21. United States Food and Drug Administration. Guidance for Industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Available at: http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf. Accessed October 9, 2014.
22. W.M. Grant Further studies on facility of flow through the trabecular meshwork AMA Arch Ophthalmol 60 4 Part 1 1958 523 533
23. B.A. Ellingsen, and W.M. Grant The relationship of pressure and aqueous outflow in enucleated human eyes Invest Ophthalmol 10 1971 430 437
24. L.G. Katz, W.C. Steinmann, A. Kabir, and et al. Selective laser trabeculoplasty versus medical therapy as initial treatment of glaucoma: a prospective, randomized trial J Glaucoma 21 2012 460 468
25. M.S. Juzych, V. Chopra, M.R. Banitt, and et al. Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma Ophthalmology 111 2004 1853 1859
26. C.P. Cannon Clinical perspectives in the use of composite endpoints Controlled Clin Trials 18 1997 517 529
27. I. Ferreira-Gonzalez Methodologic discussions for using and interpreting composite endpoints are limited but still identify major concerns J Clin Epid 60 2007 651 657
28. C.J. Kowalski Composite Endpoints: sometimes more than a solely economic consideration Am J Clin Exp Med 1 2013 24 34